Probing pyrazolo-pyrimidines as SIRT2 inhibitors via molecular modelling and biological assays
Francesca Musumeci, Cecilia Astigiano, Naomi Scarano, Marta Falesiedi, Giorgia Guccione, Jade Calamano, Annalisa Salis, Caterina Miro, Chiara Brullo, Monica Dentice, Elena Cichero, Santina Bruzzone, Silvia Schenone · 2026
Read Probing pyrazolo-pyrimidines as SIRT2 inhibitors via molecular modelling and biological assays by Francesca Musumeci, Cecilia Astigiano, Naomi Scarano, Marta Falesiedi, Giorgia Guccione, Jade Calamano, Annalisa Salis, Caterina Miro, Chiara Brullo, Monica Dentice, Elena Cichero, Santina Bruzzone, Silvia Schenone (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13418409.txt.
Description
Francesca Musumeci and colleagues refine a family of compounds that block SIRT2, an enzyme linked to cancer and brain disease, in a 2026 modelling and assay study. Computer screening of pyrazolo-pyrimidine relatives filtered a new series with stronger action than the group's earlier leads. Predicted contacts matched those of known reference blockers.
Lab assays confirmed the strategy. Two compounds stood out with very low concentrations needed for half inhibition, in the sub micromolar range. SIRT2 helps cancer cells in several settings, so selective blockers are sought as research tools and drug leads. Further biological work on the two leads is planned.
Catalog record
| CREATOR | Francesca Musumeci, Cecilia Astigiano, Naomi Scarano, Marta Falesiedi, Giorgia Guccione, Jade Calamano, Annalisa Salis, Caterina Miro, Chiara Brullo, Monica Dentice, Elena Cichero, Santina Bruzzone, Silvia Schenone |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |